Rapid transformation of low-grade endometrial stromal sarcoma to BCOR-rearranged high-grade endometrial stromal sarcoma in a patient with Birt–Hogg–Dubé syndrome: A case report
- 1Department of Obstetrics and Gynecology, University Hospital, Mizonokuchi, Teikyo University School of Medicine, 5-1-1 Futako, Takatsu-ku, Kawasaki, Kanagawa, Japan
- 2Department of Pathology, University Hospital, Mizonokuchi, Teikyo University School of Medicine, 5-1-1 Futako, Takatsu-ku, Kawasaki, Kanagawa, Japan
Abstract
[Background] Low-grade endometrial stromal sarcoma (LG-ESS) generally follows an indolent clinical course, and high-grade transformation during disease progression is rare. [Case Presentation] We report a 44-year-old woman with Birt–Hogg–Dubé (BHD) syndrome who developed rapid transformation of LG-ESS to high-grade endometrial stromal sarcoma (HG-ESS). The patient underwent surgery for a presumed uterine leiomyoma and was diagnosed with FIGO stage IA LG-ESS. Six months after surgery, a vaginal cuff recurrence was detected and rapidly progressed despite letrozole treatment. Cytoreductive surgery was performed, and the recurrent tumor was diagnosed as HG-ESS. Re-review of the primary specimen revealed no high-grade component. Comprehensive genomic profiling of the recurrent tumor identified a ZC3H7B–BCOR fusion and MDM2 amplification, in addition to the germline pathogenic FLCN variant associated with BHD syndrome. Doxorubicin achieved a partial response, but the disease subsequently progressed during further treatment. This case demonstrates exceptionally rapid transformation from LG-ESS to BCOR-rearranged HG-ESS within 6 months. Although the temporal acquisition of the BCOR rearrangement could not be established because molecular testing was not performed on the primary tumor, the marked morphologic and clinical progression supports substantial tumor evolution. The identification of BCOR rearrangement and MDM2 amplification may provide insight into the aggressive clinical course. [Conclusions] This case highlights the potential value of comprehensive genomic profiling in recurrent ESS and suggests that MDM2 inhibitors may represent a future treatment strategy for selected patients.
Related
- Persistently elevated estradiol after bilateral salpingo-oophorectomy in recurrent low-grade endometrial stromal sarcoma: a case report
- Locally Advanced Primary Cervical Endometrial Stromal Sarcoma: A Case Report.
- Interplay of NuA4/TIP60 and PRC2 Complex Activities in Fusion Driven Endometrial Stromal Sarcoma
- CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases
- Uterine Carcinosarcoma With an Adenosquamous Carcinoma and Low-Grade Endometrial Stromal Sarcoma-like Component: A Case Report
BibTeX
@article{okubo2026rapid,
title = {{Rapid transformation of low-grade endometrial stromal sarcoma to BCOR-rearranged high-grade endometrial stromal sarcoma in a patient with Birt–Hogg–Dubé syndrome: A case report}},
author = {Eko Okubo and Satoko Eguchi and Hiroko Tsuchiya and Reiko Matsuyama and Akihisa Fujimoto and Osamu Nishii and Tatsuya Aso and Mikiko Takahashi},
journal = {Gynecologic Oncology Reports},
year = {2026},
month = oct,
doi = {10.1016/j.gore.2026.102238},
url = {https://doi.org/10.1016/j.gore.2026.102238},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Rapid transformation of low-grade endometrial stromal sarcoma to BCOR-rearranged high-grade endometrial stromal sarcoma in a patient with Birt–Hogg–Dubé syndrome: A case report
AU - Eko Okubo
AU - Satoko Eguchi
AU - Hiroko Tsuchiya
AU - Reiko Matsuyama
AU - Akihisa Fujimoto
AU - Osamu Nishii
AU - Tatsuya Aso
AU - Mikiko Takahashi
PY - 2026
DA - 2026/10/21
JO - Gynecologic Oncology Reports
DO - 10.1016/j.gore.2026.102238
UR - https://doi.org/10.1016/j.gore.2026.102238
AB - [Background] Low-grade endometrial stromal sarcoma (LG-ESS) generally follows an indolent clinical course, and high-grade transformation during disease progression is rare. [Case Presentation] We report a 44-year-old woman with Birt–Hogg–Dubé (BHD) syndrome who developed rapid transformation of LG-ESS to high-grade endometrial stromal sarcoma (HG-ESS). The patient underwent surgery for a presumed uterine leiomyoma and was diagnosed with FIGO stage IA LG-ESS. Six months after surgery, a vaginal cuff recurrence was detected and rapidly progressed despite letrozole treatment. Cytoreductive surgery was performed, and the recurrent tumor was diagnosed as HG-ESS. Re-review of the primary specimen revealed no high-grade component. Comprehensive genomic profiling of the recurrent tumor identified a ZC3H7B–BCOR fusion and MDM2 amplification, in addition to the germline pathogenic FLCN variant associated with BHD syndrome. Doxorubicin achieved a partial response, but the disease subsequently progressed during further treatment. This case demonstrates exceptionally rapid transformation from LG-ESS to BCOR-rearranged HG-ESS within 6 months. Although the temporal acquisition of the BCOR rearrangement could not be established because molecular testing was not performed on the primary tumor, the marked morphologic and clinical progression supports substantial tumor evolution. The identification of BCOR rearrangement and MDM2 amplification may provide insight into the aggressive clinical course. [Conclusions] This case highlights the potential value of comprehensive genomic profiling in recurrent ESS and suggests that MDM2 inhibitors may represent a future treatment strategy for selected patients.
SN - 2352-5789
ER -